Gerald Schrenk

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Azienda Ospedaliera Universitaria Integrata Verona(Current)

Baxalta (United States)

Takeda (Austria)

Gerald Schrenk is an author at Azienda Ospedaliera Universitaria Integrata Verona specializing in hemostasis, von willebrand factor function, and medicine.

ORCID

Publications per year

2015–2023

Publications

Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

Peter L. Turecek, Rachel C. Peck, Savita Rangarajan et al. · Thrombosis Research · 2021 · 46 citations · Full text

Medicine, Molecular Medicine, Pathology +16

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease

Paolo Rossato, Enrica Federti, Alessandro Mattè et al. · Haematologica · 2022 · 22 citations · Full text

Medicine, Hematology, Molecular Medicine +16

Shear-Dependent Interactions of von Willebrand Factor with Factor VIII and Protease ADAMTS 13 Demonstrated at a Single Molecule Level by Atomic Force Microscopy

Klaus Bonazza, Hanspeter Rottensteiner, Gerald Schrenk et al. · Analytical Chemistry · 2015 · 19 citations

Medicine, Biochemistry, Molecular Biology +17

Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease

Paolo Rossato, Helmut Glantschnig, Fabio Canneva et al. · Journal of Thrombosis and Haemostasis · 2023 · 10 citations · Full text

Medicine, Cell Biology, Molecular Medicine +6

1–4 of 4